Medical and surgical management of keloids: A review

Journal of Drugs in Dermatology

Volumn 9, Issue 10, 2010, Pages 1249-1257

  Shockman, Soloman ^a   Paghdal, Kapila V ^b   Cohen, George ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COLLAGEN; DEXAMETHASONE; HYDROCORTISONE; IMIQUIMOD; LENS EPITHELIUM DERIVED GROWTH FACTOR; METHYLPREDNISOLONE; ONION EXTRACT; PLATELET DERIVED GROWTH FACTOR; SILICONE GEL; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE; VASCULOTROPIN; VERAPAMIL;

ARTICLE; CRYOTHERAPY; EAR LOBE; EPITHELIUM CELL; FIBROBLAST; GRANULATION TISSUE; HUMAN; HYPERPIGMENTATION; HYPERTROPHIC SCAR; HYPOPIGMENTATION; INFLAMMATORY CELL; INJURY; KELOID; LIGATION; LOW LEVEL LASER THERAPY; PAIN; PRESSURE; PROTEIN EXPRESSION; PULSED DYE LASER; RADIATION DERMATITIS; RADIOTHERAPY; RECURRENT DISEASE; SKIN ATROPHY; TELANGIECTASIA; WOUND HEALING; CLASSIFICATION; REVIEW;

HUMANS; KELOID; WOUND HEALING;

EID: 78049495837     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg. 2008;206(4):731-741.
2. Su CW, Alizadeh K, Boddie A, Lee RC. The problem scar. Clin Plast Surg. 1998;25(3):451-465. (Pubitemid 28343184)
3. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg. 1999;104(5):1435-1458. (Pubitemid 29466295)
4. Atiyeh BS, Costagliola M, Hayek SN. Keloid or hypertrophic scar: The controversy: Review of the literature. Ann Plast Surg. 2005;54(6):676-680. (Pubitemid 40726841)
5. Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today. 1998;4(1):19-24. (Pubitemid 28124795)
6. Wolfram D, Tzankov A, Pulzl P, Piza-Katzer H. Hypertrophic scars and keloids - A review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35(2):171-181.
7. Cheng LH. Keloid of the ear lobe. Laryngoscope. 1972;82(4):673-681.
8. Zuber TJ, DeWitt DE. Earlobe keloids. Am Fam Physician. 1994;49(8):1835-1841. (Pubitemid 24173531)
9. Bux S, Madaree A. Keloids show regional distribution of proliferative and degenerate connective tissue elements. Cells Tissues Organs. 2010;191(3):213-234.
10. Boyadjiev C, Popchristova E, Mazgalova J. Histomorphologic changes in keloids treated with Kenacort. J Trauma. 1995;38(2):299-302.
11. Amadeu T, Braune A, Mandarim-de-Lacerda C, et al. Vascularization pattern in hypertrophic scars and keloids: A stereological analysis. Pathol Res Pract. 2003;199(7):469-473. (Pubitemid 37107305)
12. Marneros AG, Norris JE, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol. 2001;137(11):1429-1434. (Pubitemid 33064238)
13. Seifert O, Mrowietz U. Keloid scarring: Bench and bedside. Arch Dermatol Res. 2009;301(4):259-272.
14. Muir IF. On the nature of keloid and hypertrophic scars. Br J Plast Surg. 1990;43(1):61-69.
15. Mofikoya BO, Adeyemo WL, Abdus-salam AA. Keloid and hypertrophic scars: A review of recent developments in pathogenesis and management. Nig Q J Hosp Med. 2007;17(4):134-139.
16. Moustafa MF, Abdel-Fattah MA, Abdel-Fattah DC. Presumptive evidence of the effect of pregnancy estrogens on keloid growth. Case report. Plast Reconstr Surg. 1975;56(4):450-453.
17. Bran GM, Goessler UR, Hormann K, et al. Keloids: Current concepts of pathogenesis (Review). Int J Mol Med. 2009;24(3):283-293.
18. Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am. 1997;77(3):701-730. (Pubitemid 27256042)
19. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995;146(1):56-66.
20. Abergel RP, Pizzurro D, Meeker CA, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol. 1985;84(5):384-390. (Pubitemid 15056660)
21. Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol. 1989;9(4):1642-1650. (Pubitemid 19095205)
22. Campaner AB, Ferreira LM, Gragnani A, et al. Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol. 2006;126(5):1168-1176.
23. Hulsbergen Henning JP, Roskam Y, Van Gemert MJ. Treatment of keloids and hypertrophic scars with an argon laser. Lasers Surg Med. 1986;6(1):72-75. (Pubitemid 16141368)
24. Khoo YT, Ong CT, Mukhopadhyay A, et al. Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis. J Cell Physiol. 2006;208(2):336-343. (Pubitemid 43993424)
25. Lu F, Gao J, Ogawa R, et al. Biological differences between fibroblasts derived from peripheral and central areas of keloid tissues. Plast Reconstr Surg. 2007;120(3):625-630. (Pubitemid 47258277)
26. Younai S, Venters G, Vu S, et al. Role of growth factors in scar contraction: An in vitro analysis. Ann Plast Surg. 1996;36(5):495-501. (Pubitemid 26153884)
27. Haisa M, Okochi H, Grotendorst GR. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol. 1994;103(4):560-563. (Pubitemid 24314846)
28. Kikuchi K, Kadono T, Takehara K. Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatology. 1995;190(1):4-8.
29. Wu Y, Zhang Q, Ann DK, et al. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol. 2004;286(4):C905-912.
30. Tuan TL, Zhu JY, Sun B, et al. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol. 1996;106(5):1007-1011.
31. Luo S, Benathan M, Raffoul W, et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg. 2001;107(1):87-96. (Pubitemid 32039240)
32. Sayah DN, Soo C, Shaw WW, et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res. 1999;87(2):209-216. (Pubitemid 30000588)
33. De Felice B, Garbi C, Santoriello M, et al. Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts. Mol Cell Biochem. 2009;327(1-2):191-201.
34. Aarabi S, Bhatt KA, Shi Y, et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J. 2007;21(12):3250-3261. (Pubitemid 47565543)
35. Ghaffari A, Kilani RT, Ghahary A. Keratinocyte-conditioned media regulate collagen expression in dermal fibroblasts. J Invest Dermatol. 2009;129(2):340-347.
36. Lim IJ, Phan TT, Song C, et al. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg. 2001;107(3):797-808. (Pubitemid 32180128)
37. Funayama E, Chodon T, Oyama A, Sugihara T. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: An important role in the pathogenesis of keloid. J Invest Dermatol. 2003;121(6):1326-1331. (Pubitemid 38005480)
38. Lim CP, Phan TT, Lim IJ, Cao X. Cytokine profiling and Stat3 phosphorylation in epithelial-mesenchymal interactions between keloid keratinocytes and fibroblasts. J Invest Dermatol. 2009;129(4):851-861.
39. Bayat A, Arscott G, Ollier WE, et al. Description of site-specific morphology of keloid phenotypes in an Afrocaribbean population. Br J Plast Surg. 2004;57(2):122-133. (Pubitemid 38239884)
40. Abdel-Fattah AM. Three distinct varieties of ear lobe keloids in Egypt. Br J Plast Surg. 1978;31(3):261-262. (Pubitemid 8383878)
41. Kelly AP. Surgical treatment of keloids secondary to ear piercing. J Natl Med Assoc. 1978;70(5):349-350.
42. Slobodkin D. Why more keloids on back than on front of earlobe. Lancet. 1990;335(8694):923-924. (Pubitemid 20136833)
43. Howell S, Warpeha R, Brent B. A technique for excising earlobe keloids. Surg Gynecol Obstet. 1975;141(3):438.
44. Robles DT, Moore E, Draznin M, Berg D. Keloids: Pathophysiology and management. Dermatol Online J. 2007;13(3):9.
45. Coppa LM, Alam M, Longley BJ, Stiller MJ. Eruptive paraneoplastic keloids. Cutis. 1999;64(4):243-244.
46. Sorabjee JS, Garje R. Reactivation of old scars: Inevitably sarcoid. Postgrad Med J. 2005;81(951):60-61. (Pubitemid 40187140)
47. Bremmer M, Deng A, Martin DB. Spontaneous eruptive keloid-like cutaneous lesions in a renal transplant patient: A form of nephrogenic systemic fibrosis? J Dermatolog Treat. 2009;20(1):63-66.
48. George AO, Akanji AO, Nduka EU, et al. Clinical, biochemical and morphologic features of acne keloidalis in a black population. Int J Dermatol. 1993;32(10):714-716. (Pubitemid 23326980)
49. Ogunbiyi A, George A. Acne keloidalis in females: Case report and review of literature. J Natl Med Assoc. 2005;97(5):736-738. (Pubitemid 40577996)
50. Sperling LC, Homoky C, Pratt L, Sau P. Acne keloidalis is a form of primary scarring alopecia. Arch Dermatol. 2000;136(4):479-484. (Pubitemid 30212959)
51. Herzberg AJ, Dinehart SM, Kerns BJ, Pollack SV. Acne keloidalis. Transverse microscopy, immunohistochemistry, and electron microscopy. Am J Dermatopathol. 1990;12(2):109-121. (Pubitemid 20122144)
52. Kelly AP. Pseudofolliculitis barbae and acne keloidalis nuchae. Dermatol Clin. 2003;21(4):645-653. (Pubitemid 38005079)
53. Durani P, Bayat A. Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg. 2008;61(1):4-17. (Pubitemid 350199116)
54. Murray JC. Keloids and hypertrophic scars. Clin Dermatol. 1994;12(1):27-37. (Pubitemid 24050735)
55. Donkor P. Head and neck keloid: Treatment by core excision and delayed intralesional injection of steroid. J Oral Maxillofac Surg. 2007;65(7):1292- 1296. (Pubitemid 46915475)
56. Engrav LH, Gottlieb JR, Millard SP, et al. A comparison of intramarginal and extramarginal excision of hypertrophic burn scars. Plast Reconstr Surg. 1988;81(1):40-45.
57. Bajaj V, Langtry JA. Surgical excision of acne keloidalis nuchae with secondary intention healing. Clin Exp Dermatol. 2008;33(1):53-55. (Pubitemid 350308522)
58. Parikh DA, Ridgway JM, Ge NN. Keloid banding using suture ligature: A novel technique and review of literature. Laryngoscope. 2008;118(11):1960-1965.
59. Ketchum LD, Smith J, Robinson DW, Masters FW. The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast Reconstr Surg. 1966;38(3):209-218.
60. Roques C, Teot L. The use of corticosteroids to treat keloids: A review. Int J Low Extrem Wounds. 2008;7(3):137-145.
61. Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560-571. (Pubitemid 34815962)
62. Berman B, Bieley HC. Keloids. J Am Acad Dermatol. 1995;33(1):117-123.
63. Kiil J. Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. Scand J Plast Reconstr Surg. 1977;11(2):169-172. (Pubitemid 8289059)
64. Koc E, Arca E, Surucu B, Kurumlu Z. An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids. Dermatol Surg. 2008;34(11):1507-1514.
65. Yosipovitch G, Widijanti Sugeng M, Goon A, et al. A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: A controlled study. J Dermatolog Treat. 2001;12(2):87-90. (Pubitemid 33009887)
66. Linares HA, Larson DL, Willis-Galstaun BA. Historical notes on the use of pressure in the treatment of hypertrophic scars or keloids. Burns. 1993;19(1):17-21. (Pubitemid 23059384)
67. Urioste SS, Arndt KA, Dover JS. Keloids and hypertrophic scars: Review and treatment strategies. Semin Cutan Med Surg. 1999;18(2):159-171. (Pubitemid 29262972)
68. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol. 1993;19(6):529-534. (Pubitemid 24173970)
69. Dalkowski A, Fimmel S, Beutler C, Zouboulis C. Cryotherapy modifies synthetic activity and differentiation of keloidal fibroblasts in vitro. Exp Dermatol. 2003;12(5):673-681. (Pubitemid 37270730)
70. Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg. 2003;111(6):1841-1852. (Pubitemid 36532336)
71. Lahiri A, Tsiliboti D, Gaze NR. Experience with difficult keloids. Br J Plast Surg. 2001;54(7):633-635. (Pubitemid 32982638)
72. Alster TS. Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser. Ann Plast Surg. 1994;32(2):186-190. (Pubitemid 24057134)
73. Kuo YR, Jeng SF, Wang FS, et al. Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down-regulation of TGF-beta1 expression and extracellular matrix expression. Lasers Surg Med. 2004;34(2):104-108.
74. Kuo YR, Wu WS, Jeng SF, et al. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg Med. 2005;36(1):38-42.
75. Alster TS. Laser treatment of hypertrophic scars, keloids, and striae. Dermatol Clin. 1997;15(3):419-429. (Pubitemid 27251160)
76. Kluger N, Hakimi S, Del Giudice P. Keloid occurring in a tattoo after laser hair removal. Acta Derm Venereol. 2009;89(3):334-335.
77. Brissett AE, Sherris DA. Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg. 2001;17(4):263-272.
78. Borgognoni L. Biological effects of silicone gel sheeting. Wound Repair Regen. 2002;10(2):118-121. (Pubitemid 34535170)
79. De Oliveira GV, Nunes TA, Magna LA, et al. Silicone versus nonsilicone gel dressings: A controlled trial. Dermatol Surg. 2001;27(8):721-726. (Pubitemid 32738241)
80. Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: Retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg. 2003;111(2):547-553. (Pubitemid 36182286)
81. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117(1):286-300. (Pubitemid 44391579)
82. Berman B, Harrison-Balestra C, Perez OA, et al. Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study. J Drugs Dermatol. 2009;8(5):455-458.
83. Berman B, Villa A. Imiquimod 5% cream for keloid management. Dermatol Surg. 2003;29(10):1050-1051. (Pubitemid 37187537)
84. Cacao FM, Tanaka V, Messina MC. Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids. Dermatol Surg. 2009;35(4):629-633.
85. Slemp AE, Kirschner RE. Keloids and scars: A review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr. 2006;18(4):396-402. (Pubitemid 44258997)
86. Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol. 2009;34(2):219-223.
87. Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg. 2006;32(7):907-915. (Pubitemid 44034368)
88. Lee JH, Kim SE, Lee AY. Effects of interferon-alpha2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol. 2008;47(2):183-186.
89. Davison SP, Mess S, Kauffman LC, Al-Attar A. Ineffective treatment of keloids with interferon alpha-2b. Plast Reconstr Surg. 2006;117(1):247-252. (Pubitemid 44391573)
90. Wong TW, Chiu HC, Yip KM. Intralesional interferon alpha-2b has no effect in the treatment of keloids. Br J Dermatol. 1994;130(5):683-685.
91. Broker BJ, Rosen D, Amsberry J, et al. Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: A pilot study. Laryngoscope. 1996;106(12 Pt 1):1497-1501. (Pubitemid 26415257)
92. Margaret Shanthi FX, Ernest K, Dhanraj P. Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. Indian J Dermatol Venereol Leprol. 2008;74(4):343-348.
93. Lee RC, Ping JA. Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J Surg Res. 1990;49(5):463-466.
94. Zurada JM, Kriegel D, Davis IC. Topical treatments for hypertrophic scars. J Am Acad Dermatol. 2006;55(6):1024-1031. (Pubitemid 44716469)
95. Ho WS, Ying SY, Chan PC, Chan HH. Use of onion extract, heparin, allantoin gel in prevention of scarring in chinese patients having laser removal of tattoos: A prospective randomized controlled trial. Dermatol Surg. 2006;32(7):891-896. (Pubitemid 44034365)
96. Saulis AS, Mogford JH, Mustoe TA. Effect of Mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg. 2002;110(1):177-183. (Pubitemid 34686266)
97. Gragnani A, Warde M, Furtado F, Ferreira LM. Topical tamoxifen therapy in hypertrophic scars or keloids in burns. Arch Dermatol Res. Jul 28 2009 ahead of print.
98. Teofoli P, Motoki K, Lotti TM, et al. Propiomelanocortin (POMC) gene expression by normal skin and keloid fibroblasts in culture: Modulation by cytokines. Exp Dermatol. 1997;6(3):111-115. (Pubitemid 27235205)
99. Kelly AP. Update on the management of keloids. Semin Cutan Med Surg. 2009;28(2):71-76.
100. Tiede S, Ernst N, Bayat A, et al. Basic fibroblast growth factor: A potential new therapeutic tool for the treatment of hypertrophic and keloid scars. Ann Anat. 2009;191(1):33-44.
101. Zhang GY, Cheng T, Zheng MH, et al. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts. J Plast Reconstr Aesthet Surg. 2010;63(7):1209-1216.